Business Economy

Global Tick-borne Encephalitis Vaccine Market Size, Market Resilience in Times of Disruption 2024-2032

Mr Accuracyreports has published a new research report titled “

Global Tick-borne Encephalitis Vaccine Market Size By Virus Type (European TBE Virus, Far Eastern TBE Virus, Siberian TBE Virus), By End-User (Pediatric Vaccines, Adult Vaccines, Traveler Vaccines), By Geographic Scope And Forecast

” in its research database. Get a Free Sample PDF of this Research Report for more Insights with Table of Content, Research Methodology, and Graphs –

https://www.mraccuracyreports.com/request/download/5/857142/Tick-borne-Encephalitis-Vaccine-Market

The primary purpose of this market research is to understand customer needs, preferences, and behaviors. By analyzing this data, businesses can develop effective marketing strategies, improve products or services, and enhance customer satisfaction. Additionally, current market research 2024 helps identify market trends, assess the competitive landscape, and evaluate the potential for new products or servicesBrowse Complete Report Here-

https://www.mraccuracyreports.com/marketreports/5/857142/Tick-borne-Encephalitis-Vaccine-Market

Tick-borne Encephalitis Vaccine Market Size And Forecast

Tick-borne Encephalitis Vaccine Market size was valued at USD 3272.5 Million in 2021 and is projected to reach USD 5018.9 Million by 2030, growing at a CAGR of 6.3% from 2023 to 2030.

The number of vases of Tick-Borne Encephalitis is increasing rapidly and is majorly being found in many parts of Europe and Asia. Several thousand cases are reported each year and there are many other cases that do not get reported. The highest number of cases occurs in Russia. This rise in the number of cases are driving the growth of the Tick-borne Encephalitis Vaccine Market. The Global Tick-borne Encephalitis Vaccine Market report provides a holistic evaluation of the market.

Global Tick-borne Encephalitis Vaccine Market Definition

Tick-borne encephalitis (TBE) is an illness caused by a virus spread through tick bites. You can also get TBE by eating or drinking unpasteurized dairy products (such as milk and cheese) from infected goats, sheep, or cows. Tick-borne encephalitis vaccine is utilized to prevent the tick-borne encephalitis virus that spread through the bites of infected ticks which affects the spinal cord and brain. The major symptoms of tick-borne encephalitis disease include headache, high fever temperature, agitation, confusion, and sickness.

Global Tick-borne Encephalitis Vaccine Market Overview

The increasing prevalence of tick-borne encephalitis along with emerging healthcare infrastructure and government funding to advance the medical facilities in emerging economies are among the factors driving the growth of the Global Tick-borne Encephalitis Vaccine Market during the forecast period. Furthermore, increasing research and development activities to support drug and vaccine development is significantly contributing to the stimulated growth of the Global Market.

The untapped economies with unmet medical needs are a great potential market and are capable of providing lucrative opportunities for market growth during the forecast horizon. There are certain restraints and challenges faced which will hinder the overall Tick-borne Encephalitis Vaccine Market growth. the high cost of vaccines makes it difficult for the common population in emerging economies to afford them. This acts as the major restraint of the Global Market.

Global Tick-borne Encephalitis Vaccine Market Segmentation Analysis

The Global Tick-borne Encephalitis Vaccine Market is segmented on the basis of Virus Type, End-User, And Geography.

Tick-borne Encephalitis Vaccine Market, By Virus Type

  • European TBE Virus
  • Far Eastern TBE Virus
  • Siberian TBE Virus

Based on Virus Type, The market is bifurcated into European TBE Virus, Far Eastern TBE Virus, and Siberian TBE Virus. The European TBE virus accounts for the largest segment by virus type and is expected to maintain its lead during the forecast period.

Tick-borne Encephalitis Vaccine Market, By End-User

  • Pediatric Vaccines
  • Adult Vaccines
  • Traveler Vaccines

Based on End-User, The market is bifurcated into Pediatric Vaccines, Adult Vaccines, and Traveler Vaccines. The traveler vaccines hold the major chunk of the end-user segment. The High-risk activities including working or camping in forested areas or farmland, adventure travel, or living in countries where TBE is present for an extended period of time are responsible for the growth of this segment.

Tick-borne Encephalitis Vaccine Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

On the basis of Regional Analysis, The Global Tick-borne Encephalitis Vaccine Market is classified into North America, Europe, Asia Pacific, and Rest of the world. North America and Europe hold the major chunk of the market. The well-developed infrastructure and ideal policies by the governments in these regions are propelling the growth and the presence of major players adds to the growth of the market. The rising awareness among people in North America & Europe is contributing to the growth of the market.

Key Players

The “Global Tick-borne Encephalitis Vaccine Market” study report will provide valuable insight with an emphasis on the global market.  The major players in the market are Pfizer Inc., The Cochrane Collaboration, Encephalitis Global, Inc., Sonic HealthPlus Pty Ltd., GlaxoSmithKline plc., Merck & Co., Inc., Baxter International Inc., London Travel Clinic., Superdrug Health Clinic. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally. 

Key Developments

Mergers and Acquisitions

  • Pfizer merged its consumer health business with that of GlaxoSmithKline in August 2019, becoming a joint venture owned 68 percent by GlaxoSmithKline and 32 percent by Pfizer, with ambitions to go public. The deal followed a 2018 transaction in which GlaxoSmithKline acquired Novartis’ interest in the GSK-Novartis consumer healthcare joint venture.

Product Launches and Product Expansions

  • Pfizer Inc. announced in February 2021 that the FDA has accepted for Priority Review the company’s Biologics License Application (BLA) for TicoVac, its tick-borne encephalitis (TBE) vaccine.

Ace Matrix Analysis

The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.

Market Attractiveness

The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Tick-borne Encephalitis Vaccine Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.

Porter’s Five Forces

The image provided would further help to get information about Porter’s five forces framework providing a blueprint for understanding the behavior of competitors and a player’s strategic positioning in the respective industry. The porter’s five forces model can be used to assess the competitive landscape in Global Tick-borne Encephalitis Vaccine Market, gauge the attractiveness of a certain sector, and assess investment possibilities.

Report Scope

REPORT ATTRIBUTES DETAILS
STUDY PERIOD

2018-2030

BASE YEAR

2021

FORECAST PERIOD

2023-2030

HISTORICAL PERIOD

2018-2020

UNIT

Value (USD Million)

KEY COMPANIES PROFILED

Pfizer Inc., The Cochrane Collaboration, Encephalitis Global, Inc., Sonic HealthPlus Pty Ltd., GlaxoSmithKline plc., Merck & Co., Inc., Baxter International Inc.

SEGMENTS COVERED
  • By Virus Type
  • By End-User
  • By Geography
CUSTOMIZATION SCOPE

Free report customization (equivalent to up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope

Top Trending Reports:

Research Methodology of Market Research:

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.

Frequently Asked Questions

Tick-borne Encephalitis Vaccine Market was valued at USD 3272.5 Million in 2021 and is projected to reach USD 5018.9 Million by 2030, growing at a CAGR of 6.3% from 2023 to 2030.